We are live on ! Find out more
LIP

Liontrust Investment Partners Portfolio holdings

AUM $6.8B
1-Year Est. Return 23.31%
This Fund
S&P 500
This Quarter Est. Return
+17.11%
1 Year Est. Return
+23.31%
3 Year Est. Return
+86.24%
5 Year Est. Return
+84.86%
10 Year Est. Return
–
AUM
$6.8B
AUM Growth
+$947M
Cap. Flow
+$302M
Cap. Flow %
4.44%
Top 10 Hldgs %
30.04%
Holding
242
New
46
Increased
60
Reduced
72
Closed
48
Avg Time Held
7.3 quarters
Top 10 Avg Time Held
6.2 quarters
Top 20 Avg Time Held
6.2 quarters

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$298M
2
DB icon
Deutsche Bank
DB
+$197M
3
SPOT icon
Spotify
SPOT
+$124M
4
UBS icon
UBS Group
UBS
+$112M
5
LIN icon
Linde
LIN
+$109M

Top Sells

Rank Stock Value
1
ARM icon
Arm
ARM
+$65.1M
2
INTU icon
Intuit
INTU
+$49.9M
3
PTC icon
PTC
PTC
+$39.9M
4
MU icon
Micron Technology
MU
+$39.2M
5
AMAT icon
Applied Materials
AMAT
+$31.9M

Sector Composition

Rank Sector Weight
1 Technology 27.9%
2 Healthcare 20.86%
3 Financials 15.39%
4 Industrials 12.21%
5 Communication Services 7.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
AZN icon
1
AstraZeneca
AZN
$242B
$297M 4.36%
+1,586,940
New +$298M
2026 Q2
0 quarters
TSM icon
2
TSMC
TSM
$2.31T
$267M 3.93%
559,772
+39,214
+8% +$15.9M
2020 Q4
22 quarters
GOOGL icon
3
Alphabet (Google) Class A
GOOGL
$4.33T
$259M 3.8%
723,493
+82,440
+13% +$29.7M
2020 Q4
22 quarters
AVGO icon
4
Broadcom
AVGO
$1.71T
$243M 3.57%
642,254
+22,702
+4% +$9.1M
2023 Q2
12 quarters
DB icon
5
Deutsche Bank
DB
$62.6B
$205M 3.02%
+6,064,095
New +$197M
2026 Q2
0 quarters
TMO icon
6
Thermo Fisher Scientific
TMO
$245B
$182M 2.67%
362,213
+101,547
+39% +$48.7M
2020 Q4
22 quarters
V icon
7
Visa
V
$744B
$163M 2.39%
474,452
+5,323
+1% +$1.71M
2020 Q4
22 quarters
CDNS icon
8
Cadence Design Systems
CDNS
$92B
$150M 2.2%
398,713
+30,538
+8% +$10.7M
2020 Q4
22 quarters
WST icon
9
West Pharmaceutical
WST
$26.2B
$144M 2.12%
402,233
+65,238
+19% +$19.9M
2025 Q4
2 quarters
WAT icon
10
Waters Corp
WAT
$42.2B
$135M 1.98%
358,979
+60,124
+20% +$20.5M
2023 Q3
11 quarters
NVDA icon
11
NVIDIA
NVDA
$5.52T
$131M 1.93%
655,849
+46,063
+8% +$9.47M
2020 Q4
22 quarters
UBS icon
12
UBS Group
UBS
$147B
$122M 1.79%
+2,458,659
New +$112M
2026 Q2
0 quarters
SCHW icon
13
Charles Schwab
SCHW
$166B
$120M 1.77%
1,305,310
+102,662
+9% +$9.36M
2020 Q4
22 quarters
MA icon
14
Mastercard
MA
$530B
$120M 1.76%
232,762
+377
+0.2% +$188K
2020 Q4
22 quarters
SPOT icon
15
Spotify
SPOT
$108B
$119M 1.75%
+259,680
New +$124M
2026 Q2
0 quarters
VLTO icon
16
Veralto
VLTO
$24.1B
$114M 1.68%
1,286,674
+77,927
+6% +$6.77M
2023 Q4
10 quarters
ISRG icon
17
Intuitive Surgical
ISRG
$149B
$114M 1.67%
285,872
+20,909
+8% +$9.13M
2020 Q4
22 quarters
IDXX icon
18
Idexx Laboratories
IDXX
$41B
$113M 1.66%
215,198
+37,861
+21% +$21.2M
2024 Q4
6 quarters
CTAS icon
19
Cintas
CTAS
$81.9B
$113M 1.66%
663,625
+39,025
+6% +$6.75M
2025 Q4
2 quarters
LIN icon
20
Linde
LIN
$227B
$111M 1.64%
+214,571
New +$109M
2026 Q2
0 quarters
EW icon
21
Edwards Lifesciences
EW
$49.1B
$110M 1.62%
1,216,379
+78,008
+7% +$6.53M
2023 Q3
11 quarters
MPWR icon
22
Monolithic Power Systems
MPWR
$64.8B
$105M 1.54%
75,786
+4,520
+6% +$6.79M
2024 Q4
6 quarters
BDX icon
23
Becton Dickinson
BDX
$51B
$102M 1.5%
674,555
+29,247
+5% +$4.37M
2025 Q1
5 quarters
EXC icon
24
Exelon
EXC
$43.6B
$97.7M 1.44%
2,096,030
+36,977
+2% +$1.71M
2025 Q1
5 quarters
PGR icon
25
Progressive
PGR
$129B
$97.2M 1.43%
445,001
+133,951
+43% +$27M
2025 Q4
2 quarters
1
2 3 4 5

Similar funds

TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
CAI
Capital Advisors Inc Tulsa, Oklahoma $6.8B AUM 26.96% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.77B AUM 38.11% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.76B AUM 18.39% 1-Year Est. Return
EWM
Empirical Wealth Management Seattle, Washington $6.85B AUM 30.02% 1-Year Est. Return
MCM
Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $6.74B AUM 30.22% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

Liontrust Investment Partners's Q2 2026 Portfolio in Review

As of Q2 2026, Liontrust Investment Partners held 242 positions worth $6.8B, up 16% from $5.86B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Liontrust Investment Partners deployed $302M of net new capital in Q2 2026, opening 46 new positions and adding to 60 existing holdings. Its largest new stake was AstraZeneca: 1,586,940 shares worth $297M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Arm, an estimated $65.1M trimmed.

  • Liontrust Investment Partners's largest Q2 2026 buy was AstraZeneca: 1,586,940 shares worth $297M.
  • Liontrust Investment Partners added most to Ferguson in Q2 2026, an estimated $79.5M increase.
  • Liontrust Investment Partners's biggest Q2 2026 reduction was Arm, cutting an estimated $65.1M.
  • Liontrust Investment Partners fully exited Ciena in Q2 2026, selling an estimated $31.9M.
  • Liontrust Investment Partners's ten largest holdings make up 30% of its $6.8B portfolio in Q2 2026.
  • Liontrust Investment Partners opened 46 new positions and closed 48 in Q2 2026.
  • Liontrust Investment Partners's portfolio value rose 16% quarter-over-quarter to $6.8B.

Based on Liontrust Investment Partners's 13F filing for Q2 2026, filed 18 Aug 2026.